
Scientific & Clinical Advisors
Piton Therapeutics is guided by a world-class network of scientific and clinical advisors who are leaders in their respective fields, spanning immunology, neurology, microbiome science, pharmacology, and clinical development. Their expertise ensures our therapeutic strategies are grounded in cutting-edge science and aligned with real-world clinical needs. These trusted advisors provide critical insight that shapes our R&D priorities, informs our translational approach, and accelerates our path toward delivering impactful, precision-based therapies to patients.
Alessio Fasano, MD
Gastroenterology & Microbiome
Christopher McDougle, MD
Psychiatry & Autism
Andrew Goodman, Ph.D.
Microbial Genetics
Krishna Kumar, Ph.D.
Chemistry & Drug Development
Dong Kong, Ph.D.
Neuroscience & Gut-Brain Axis & Imaging Scientific Founder, Chairman of Board & SAB
Maude M. David, Ph.D.
Associate Professor
Department of Microbiology
Learn about Piton’s AI-powered platform
At Piton Therapeutics, we are revolutionizing precision medicine through our state-of-the-art AI-powered platform, unlocking novel small-molecule therapeutics that target the gut-brain axis with unparalleled specificity.